Suchergebnisse - "Sessa, C"

PubPharm (34)

1

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Stathis, A. | Hess, D. | von Moos, R. | +13

2

A phase Ib dose-escalation study of the MEK inhibitor trametinib in combination with the PI3K/mTOR inhibitor GSK2126458 in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2016

von Grilley-Olson, J. | Bedard, P. | Fasolo, A. | +13

3

A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas

enthalten in: European journal of cancer (Oxford, England : 1990) | 2016

von Fiedler, W. | DeDosso, S. | Cresta, S. | +8

4

An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib

enthalten in: Targeted oncology | 2016

von Mateo, J. | Moreno, V. | Gupta, A. | +15

5

Integrative population pharmacokinetic and pharmacodynamic dose finding approach of the new camptothecin compound namitecan (ST1968)

enthalten in: British journal of clinical pharmacology | 2015

von Joerger, M. | Hess, D. | Delmonte, A. | +7

6

Phase-I dose finding and pharmacokinetic study of the novel hydrophilic camptothecin ST-1968 (namitecan) in patients with solid tumors

enthalten in: Investigational new drugs | 2015

von Joerger, M. | Hess, D. | Delmonte, A. | +4

7

Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours

enthalten in: British journal of cancer | 2014

von Del Conte, G. | Sessa, C. | von Moos, R. | +8

8

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Macaulay, V. | Middleton, M. | Protheroe, A. | +8

9

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Sessa, C. | Tosi, D. | Viganò, L. | +12

10

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2009

von Sessa, C. | Cresta, S. | Noberasco, C. | +11